Susan Hasty, Publisher
Table of Contents . . . February 19th, 1996Non-Subscriber - Summaries Only
Conference Coverage (Retrovirus) - Cell Genesys Gene Therapy Safe in Early Trial
Conference Coverage (Retrovirus) - Chemokines Can Both Suppress and Activate HIV
Conference Coverage (Retrovirus) - Tiny Region of HIV Gene Missing in Long-Term Non-Progressors
Antisense Technology - ODNs May Offer Alternative Antimalarial Strategy
Cancer Gene Therapy - Bystander Effect Explored in Hepatocellular Carcinoma Model
Cancer Gene Therapy - Ovarian Cancer Succumbs to Antibody-Targeted Gene Therapy
Gene Discovery (CLCN5) - Doctors Find Gene for Kidney Stones
Gene Transfer (HSA) - Marker Gene Transduction Allows for Cell Selection Within 24 Hours
Genetics (Breast Cancer) - Mutations in P53 Gene Predict Need for Aggressive Cancer Treatment
HIV Gene Therapy - City of Hope Awarded Grant To Investigate Gene Therapy
HIV Gene Therapy - Virion-Targeted Viral Inactivation Weakens HIV
Industry News (Joint Venture) - Collaboration Established on Intracellular Gene Therapy
Industry News (Patents and Technology) - Licensed Gene Delivery Technology Receives Australian Patent
Vectors (Alternative) - Foamy Virus Examined for Gene Therapy Vector Potential
Vectors (Retroviral) - Tetracycline-Regulated Retroviral Vector System Improved
HIV Gene Therapy - "DNA Vaccination: Vaccine/Immune Therapeutic Intervention for HIV-1."
HIV Vaccine - "A Live Inactivatable Attenuated Vaccine For AIDS."
Vectors - "Vectors for Gene Therapy."
Antisense Technology - "Antisense Strategies in the Treatment of Hematological Malignancies."
Antisense Technology - "Effect of Different Chemically Modified Oligodeoxynucleotides on Immune Stimulation."
HIV Gene Therapy - "Stem Cells As Vehicles for Gene Therapy: Novel Strategy for HIV Infection."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.